Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-17-005010
Filing Date
2017-05-23
Accepted
2017-05-23 06:30:03
Documents
1
Period of Report
2017-05-23

Document Format Files

Seq Description Document Type Size
1 BYDUREON EXSCEL TRIAL MEETS T2D SAFETY OBJECTIVE a9300f.htm 6-K 43132
  Complete submission text file 0001654954-17-005010.txt   44257
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 17862630
SIC: 2834 Pharmaceutical Preparations